The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum
- PMID: 37610113
- PMCID: PMC10512855
- DOI: 10.18553/jmcp.2023.29.9.1078
The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum
References
-
- DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer’s disease: Correlation with cognitive severity. Ann Neurol. 1990;27(5):457-64. doi:10.1002/ana.410270502 - PubMed
-
- Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278(16):1349-56. - PubMed
-
- 2022 Alzheimer’s disease facts and figures. Alzheimers Dement. 2022;18(4):700-89. doi:10.1002/alz.12638 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
